to a mixed fat/carbohydrate diet (Postic et al., 1994) . Thus, in adult cardiac cells, fatty acids are the main sub strate between meals, whereas during meals when high glucose and insulin are present, glucose also becomes an important substrate for oxidative metabolism (Depre et al., 1999) .
In noncardiac proliferating tumor cells, Wilson and others (Rose and Warms, 1967; Gottlob et al., 2001; Wilson, 2003; Majewski et al., 2004; Galluzzi et al., 2008; Miyamoto et al., 2008; GimenezCassina et al., 2009) have suggested that HKI and HKII have different roles related to their intracellular location and regulatory properties, with HKI being primarily associated with mitochondria to deliver G6P to the catabolic glycolytic pathway and the tricarboxylic acid cycle (TCA) cycle. HKII fulfills a similar function when bound to mito chondria, but also translocates to the cytoplasm, where it preferentially directs G6P to glycogen synthesis and (presumably) other anabolic pathways. They showed biochemically that the interaction of HKII with mito chondria was not static, but was dynamically regulated by factors such as extracellular glucose, intracellular G6P, and kinases such as Akt and GSK3.
We have recently expressed HKI and HKII tagged with YFP in Chinese hamster ovary (CHO) cells to track Hexokinase-mitochondrial interactions regulate glucose metabolism differentially in adult and neonatal cardiac myocytes were isolated with the use of a Percoll (GE Healthcare) gradi ent and plated on 35mm glassbottom culture dishes. Adult rat ventricular myocytes (ARVM) were enzymatically isolated from the heart of 3-4moold male Fisher rats as described previously (Goldhaber et al., 1989) . In brief, after administering anesthe sia, hearts were removed and perfused retrogradely at 37°C in Langendorff fashion with nominally Ca 2+ free Tyrode's buffer containing 1.2 mg/ml collagenase type II (catalog No. 4176; Worthington Biochemical Corporation) and 0.12 mg/ml pro tease type XIV (catalog No. P5147; SigmaAldrich) for 25-28 min. After washing out the enzyme solution, hearts were subsequently removed from the perfusion apparatus and gently agitated to dissociate the myocytes. The Ca 2+ concentration was gradually increased to 1.8 mmol/liter over 30 min. This procedure typi cally yielded 40-60% of rodshaped, Ca 2+ tolerant myocytes that were then plated on 35mm glassbottom culture dishes. NRVM and ARVM were cultured in DMEM high (25 mM) glucose me dium supplemented with 6% (vol/vol) FBS, 100 U/ml penicillin, 100 U/ml streptomycin, and 2 mM glutamine.
Solutions and experimental techniques
The bath solution for cell imaging consisted of (in mM) 140 NaCl, 5 KCl, 1.1 MgCl 2 , 2.5 CaCl 2 , and 10 HEPES, with the pH adjusted to 7.2 with KOH. Glucose was added to this solution, and for the 0 glucose solution Nmethyldglucamine (NMDG) was added to maintain the solution's osmolarity. Solutions were perfused di rectly over the cells using a gravity fed eight way perfusion device (Warner Instruments) with electrically controlled solenoids (The Lee Company). Input and output of solution volumes to the re cording chamber (35mm glassbottomed culture dish) were equil ibrated to maintain constant flow rates and pressures within the recording chamber. Experiments were performed at room tem perature (25°C). Cytochalasin B (Cyto B), Akt Inhibitor IV, and other chemicals were purchased from SigmaAldrich.
Plasmids constructs and transduction
We obtained the FLIPglu600 µM cDNA from W.B. Frommer (Carnegie Institution for Science, Stanford, CA), GLUT from D. Abel (University of Utah, Salt Lake City, UT), and rat HKI and HKII from J. Wilson. Fusion of rat HKs to YFP was accom plished by inserting a Bam H1 site at the last amino acid of the coding sequence and subcloning into a modified pEYFPN1 vec tor (Takara Bio Inc.). The modified pEYFPN1 carried the mu tations Q86K and A206K. All constructs were subcloned into the mammalian expression vectors using the cytomegalovirus (CMV) promoter.
Overexpression of FLIPglu600 µM, HKI, and HKII in NRVM and ARVM was achieved with engineered adenoviruses encoding the constructs. Expression of the constructs was sufficiently high after 36-48 h (NRVM) and 72-96 h (ARVM) to perform FRET experiments or microscopy imaging.
RNA interference with short hairpin RNA (shRNA) Biologically active shRNAs were generated from the pLKO. 1puro vector system (Naldini et al., 1996; Zufferey et al., 1997) . The shRNA target sequences for HKI and HKII were purchased from Thermo Fischer Scientific. The pLKO.1scramble (Add gene) was used as a control for RNA interference. To accomplish transgene incorporation into lentiviral capsids, pLKO.1 vectors were cotransfected with pSPAX.2 packaging vector (encoding HIV Gag, pol, and Rev proteins) in combination with pMD2.G (encoding VSVG glycoprotein) into HEK293T cells plated on 6cm dishes using Lipofectamine 2000. The medium was then re placed with complete DMEM containing 10% FBS, and the virus containing supernatants were harvested 48, 72, and 96 h after transfection. All virus stocks were filtered at 0.45 µm, aliquoted, and stored at 80°C. their subcellular locations in real time in response to vari ous substrates, while measuring concomitant changes in intra cellular glucose using a genetically encoded intracel lular glucose biosensor (John et al., 2011) . These studies directly demonstrated that HKII dynamically translocates from mitochondria, where it directs glucose catabolically toward glycolysis, to the cytoplasm, where it directs glu cose anabolically toward glycogen synthesis; consistent with the Wilson hypothesis, such translocation occurs in response to changes in glucose, iodoacetate (IAA), or Akt signaling. In contrast, under all of the same conditions, HKI remained strongly associated with mitochondria to promote glycolysis (John et al., 2011) . Collectively, a picture has emerged whereby HKI is singlepurposed, re maining predominantly bound to mitochondria, where its primary role is to facilitate glycolysis, although under some specific nonphysiological conditions it may contrib ute to glycogen synthesis (Cifuentes et al., 2008) . HKII, however, plays a multifunctional role: channeling G6P into the glycogen and anabolic pathways such as the pen tose phosphate shunt when present in the cytoplasm, and preferentially shuttling G6P to glycolysis and oxidative phosphorylation when bound to mitochondria (Rose and Warms, 1967; Sui and Wilson, 1997; Gottlob et al., 2001; Majewski et al., 2004; Pastorino et al., 2005; Skaff et al., 2005; Galluzzi et al., 2008; Jurczak et al., 2008; Miyamoto et al., 2008; GimenezCassina et al., 2009) .
These findings from tumor cell lines, which are well known to have altered glycolytic metabolism (the Warburg effect), raise the question of whether differential roles of HK isoforms are also important in physiologically normal tissues. To examine this question, we investi gated whether the profoundly higher glycolytic activity of neonatal hearts compared with adult hearts may be related to their differences in HK isoform expression, using a set of novel genetically encoded optical imaging tools to track, in realtime in living neonatal and adult cardiac myocytes, the subcellular distributions of HKI and HKII, as well as the functional consequences on glucose utilization. Neonatal and adult rat ventricular myocyte culture Neonatal rat ventricular myocytes (NRVM) were enzymatically isolated by standard methods (Rohr et al., 1991) . In brief, hearts harvested from 2-3dold neonatal SpragueDawley rats were digested with collagenase (0.02%; Worthington Biochemical Corporation) and pancreatin (0.06%; SigmaAldrich). Myocytes
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Data analysis
Analysis of images and FRET data were implemented in the Python programming language (van Rossum and Drake, 2001) , using the Numpy and Scipy packages that provide support for array manipulation and general scientific computation, respec tively (Oliphant, 2007) .
Translocation of HKs from mitochondria to cytoplasm was quantified by measuring the spatial variance in fluorescence over time. Because mitochondria are discrete organelles, the spatial variance is large when HK fluorescence arises predominantly from mitochondria, and decreases as HK is released and diffuses evenly through the cytoplasm (see the example in Fig. S1 ). The variance operator is a local neighborhood operation that calculates the sum of square of the brightness differences from the mean for the neighborhood surrounding each pixel in the original image (Russ, 2011) . The variance value is small in regions of the image with uniform brightness and becomes large whenever sharp dark bright transitions occur. In our algorithm, for each pixel in the input image, the variance was calculated for a 9by9 to 15by15 group of surrounding pixels, using the following formula: 
where x 0 , an estimate of the time requires to reach half of the change in FRET ratio, accounts for the lag period, whereas s, an estimate of the rate of change, is more or less independent of the lag period. a and b are, respectively, the lower and upper asymp totes of the sigmoid function.
Statistical analysis
For each dataset, the mean and accompanying 95% confidence intervals (CIs) are reported. The conventional percentile boot strapresampling approach with 10,000 replications was used for estimating 95% CI as well as examining the significant difference between groups (effect size statistics; Efron and Tibshirani, 1991; Nakagawa and Cuthill, 2007; Calmettes et al., 2012) . A Pvalue <0.05 was considered statistically significant. All analyses were performed by subroutines for bootstrapping developed in the Python programming language (van Rossum and Drake, 2001), using the Numpy and Scipy packages, based on the code we previ ously published (Calmettes et al., 2012) .
Online supplemental material Fig. S1 shows principles of spatial variance-based image analy sis. Fig. S2 shows IAAinduced changes in G6P as a function of time in NRVM. Fig. S3 shows a quantification of HKI and HKII overexpression in NRVM infected by HKI and HKII adenovi ruses. Fig. S4 shows a quantification of the differential expres sion of GLUT and HK isoforms in neonatal and adult hearts. Fig. S5 shows effects of IAA on NRVM glycolytic activity mea sured using the FRET glucose sensor. Fig. S6 shows effects of 0 glucose and IAA on intracellular pH in CHO cells, and the ef fects of cytosolic acidification on HKII translocation in NRVM. Fig. S7 shows calibration of the FRET glucose sensor used to calculate the rates of glucose utilization in cardiac myocytes. Online supplemental material is available at http://www.jgp.org/ cgi/content/full/jgp.201310968/DC1.
Immunoblot analysis
For immunoblot analyses, cells were lysed in a buffer containing 50 mM Tris, pH 7.5, 1% Triton X100, 150 mM NaCl, 10% glyc erol, and 1 mM EDTA. Samples were separated on 10% SDS PAGE. Proteins were transferred to nitrocellulose membranes and subsequently analyzed by immunoblotting with the relevant antibodies. Antibodies used were antiactin (clone I19), antiHKI (clone G1), and antiHKII (clone 45.6), all purchased from Santa Cruz Biotechnology, Inc. Chemiluminescence images were ac quired using an Image Reader LAS3000 LCD camera (Fujifilm). Band intensities were quantified using National Institutes of Health ImageJ software.
G-6-P assay A commercial kit (Biovision Research Products) was used for the G6P assay. NRVM grown to near confluence (2-3 × 10 6 ) were in cubated in the absence of glucose or with 100 µM IAA for periods of time ranging from 0 to 25 min. After the incubation cells were washed in icecold PBS and frozen in situ in dry ice ethanol. 200 µl of 6% (vol/vol) perchloric acid was then added and the cells scraped while frozen. Cells were homogenized via a "Qiashredder" column at 4°C and the homogenate neutralized with 500 mM ethanolamine and 10 M KOH (Taylor et al., 2006) . Samples were then centrifuged to remove insoluble material (10 min, 15,000 g at 4°C). 50µl samples were transferred into wells of a 96well plate and brought to a volume of 100 µl with assay buffer. Absorbance at 450 nm was measured, using a POLARstar Omega microplate reader (BMG LABTECH GmbH). To estimate the G6P levels a curve was generated with G6P standards containing 0, 2, 4, 6, 8, 10, and 20 nmol/well.
FRET imaging
All cells were imaged live without fixation. Images (16bit) were acquired using a microscope (Eclipse TE300; Nikon) fitted with a 60× (1.4 NA) oil immersion lens (Nikon) and equipped with a fil ter cube comprising a CFP bandpass excitation filter, 436/20b, together with a longpass dichroic mirror (455DCLP; Chroma Technology Corp). LEDs (Philips Lumileds) were used as light sources: one emitting at 455 ± 20 nm (royal blue) and the other emitting at 505 ± 15 nm (cyan). LEDs and camera exposure were controlled by MetaFluor Imaging 6.1 software (Molecular Devices). Ratiometric FRET measurements were monitored from the YFP and CFP images acquired simultaneously using a Dual View image splitter (Optical Insights) equipped with a 505nm long pass dichroic filter to separate the CFP and YFP signals, a CFP emission filter (480/30), and a YFP emission filter (535/40) (John et al., 2008 (John et al., , 2011 . Images were captured with a Cascade 512B digital camera (Photometrics). Exposure times were optimized in each case but varied between 300-500 ms and were recorded at a constant rate for each cell between 0.2 and 0.33 Hz. Many experi ments lasted >1 h, leading to a slow drift in the FRET ratio baseline in some cases.
Standard and confocal microscopy imaging
Standard microscopy images were acquired using an inverted microscope (IX70; Olympus) fitted with an Olympus PlanApo chromat 60×, 1.4 NA oil immersion objective lens and a cooled chargecoupled device (CCD) camera (Quantix; Photometrics). Imaging Workbench software was used for data acquisition and analysis. YFP (XF1042) and CFP (XF1302) filter cubes were pur chased from Omega Optical, Inc.
Confocal images were acquired using an inverted microscope (Axiovert 100 LSM; Carl Zeiss) fitted with a 60× water immer sion objective lens (CApochromat 63/1.2 W Corr; Carl Zeiss). Pascal 5 image software (Carl Zeiss) was used for data acquisi tion and analysis. the cytoplasm, as indicated by the presence of diffuse green in the merged images. These results agree with our data previously obtained in CHO cells (John et al., 2011) , confirming the hypothesis that these properties of HK iso forms are not unique to tumor cells, but also occur in na tive tissue.
HK translocation in ARVM versus NRVM
We have previously shown that removal of glucose, ex posure to the glycolytic inhibitor IAA, or expression of constitutively active Akt all regulate HK distribution in CHO cells (John et al., 2011) . Here we investigated how these interventions affect the subcellular distribution of HKI and HKII in ARVM and NRVM. For these ex periments, timelapsed confocal images of HKIYFP and HKIIYFP fluorescence were compared with the corre sponding TMRM images of the mitochondrial network in the same cell, using a customized imageprocessing algorithm that calculated the spatial variance in HKYFP and TMRM fluorescence (see Materials and methods for details and Fig. S1 ). This analysis provides accurate measurements of HK redistribution between the mi tochondrial and cytoplasm compartments over time (Fig. S1 ), but does not provide absolute levels of HK binding to the various intracellular compartments, in part because of the nonuniformity of their structures. In ARVM, the subcellular distribution of HKIIYFP was sensitive to extracellular glucose (Fig. 2) . In the pres ence of glucose, a large fraction of HKII was bound to mitochondria, and upon removal of glucose, HKII rap idly translocated to the cytosol, with a time constant av eraging 9.8 min (95% CI [8.4, 11.3] , n = 7; Fig. 2 D) . In contrast, the mitochondrial pattern of HKIYFP fluores cence did not change significantly when extracellular glucose was removed even after 40 min (Fig. 3) . This was quantified by a lack of change in the spatial vari ance of YFP fluorescence (Fig. 3 , C and D; n = 6). These results show that in ARVM, HKI binding to mitochon dria is very stable, whereas HKII binding is labile and dynamically regulated by extracellular glucose.
However, in NRVM, both HKI and HKII remained associated with mitochondria upon glucose removal (Fig. 4, A and B, white and light gray traces; n = 8 and n = 15, respectively). Because (1) Akt is known to fa cilitate HKII interaction with mitochondria (Miyamoto et al., 2008) and (2) we previously demonstrated that overexpression of constitutively active Akt in CHO cells prevented HKII translocation from mitochondria to cytoplasm in response to glucose removal (John et al., 2011) , we speculated that the higher affinity of HKII to mitochondria in NRVM could be caused by high endog enous Akt activity. However, preincubation of NRVM for 1 h with Aktinhibitor IV (10 µM) did not facilitate HKII dissociation when glucose was removed (Fig. 4 B, dark gray trace; n = 6), making this possibility unlikely. Furthermore, treatment with IAA to inhibit glycolysis R E S U L T S HK subcellular localization in AVRM and NRVM To assess the subcellular localization of HKI and HKII in cardiac myocytes, we used confocal microscopy to image living ARVM and NRVM infected with YFPtagged HKI or HKII, using an adenoviral vector. To determine whether HKs colocalized with mitochondria, the infected cells were also loaded with 30 nM tetramethylrhodamine, methyl ester (TMRM), a widely used marker of the mito chondrial network. Typical images obtained from ARVM and NRVM expressing HKYFP isoforms (green pseudo color) and loaded with TMRM (red pseudocolor) are presented in Fig. 1 (A and B, respectively) . As shown in this figure, there is almost perfect overlap (yellow) be tween the images obtained with HKIYFP and the corre sponding TMRM images. This observation suggests that HKI colocalizes with mitochondria in both ARVM and NRVM. In contrast, HKII appeared to colocalize with mi tochondria to some extent, but was also found throughout 1994), which is consistent with mRNA expression lev els measured with reverse transcription PCR (RTPCR; (Fig. S4) . In addition, our data presented in the pre vious section indicate that HKI has a stronger binding affinity to mitochondria than HKII (Figs. 1-4) . Thus, NRVM are expected to use glucose at a higher rate than ARVM, as mitochondriabound HK is more glycolytically and promote intracellular G6P accumulation (Fig. S2 ) readily caused HKII redistribution from mitochondria to cytoplasm in NRVM (Fig. 4 , C and D; n = 10).
Basal glucose handling in ARVM and NRVM
It has been reported that the HKI/HKII ratio is higher in neonatal heart than in adult heart (Postic et al., higher in ARVM than NRVM, which is consistent with enhanced glycolytic activity of NRVM. This is consis tent with the data presented in the next section where overexpression of HKI in ARVM, but not in NRVM, further increases the FRET ratio (i.e., lowered intra cellular glucose).
When extracellular glucose concentration was in creased from 0 to 10 mM, the YFP/CFP emission ratio decreased, reflecting glucose entry into the cell (Fig. 5,  A and B) . Upon removal of extracellular glucose, the ratio returned to its original value, indicating clear ance of intracellular glucose by the combined effects of glucose efflux through GLUT transporters and glu cose metabolism (Fehr et al., 2003; John et al., 2008) . To compare the rate of glucose metabolism, independently from its efflux, in NVRM and ARVM, we used Cyto B (20 µM) to block GLUTsensitive transmembrane glu cose transport (John et al., 2011) . The metabolism of glucose could then be estimated from the halftime of intracellular glucose clearance obtained by fitting the active compared with cytoplasmic HK (Southworth, 2009; John et al., 2011) . To test this hypothesis, we mea sured basal and dynamic glucose handling in ARVM and NRVM in response to varying extracellular glu cose concentrations, using the FRETbased glucose sensor FLIPglu600 µM inserted into an adenoviral vec tor to measure glucose utilization. In the Results sec tion, we have used halftimes to quantify and report the dynamic changes in intracellular glucose, but in addition, we have calibrated the FRET glucose sensor to estimate the rates of glucose entry and utilization (Fig. S7) . Fig. 5 (A and B) illustrates typical recordings of the YFP/CFP emission ratios obtained in ARVM and NRVM under comparable experimental conditions. In the absence of extracellular glucose, the baseline FRET ratio was lower in AVRM (n = 14) than in NRVM (n = 8), averaging 1.3 (95% CI [1.2, 1.4]) and 2.3 (95% CI [2.1, 2.5]), respectively. This difference, which was sta tistically significant (P < 0.01; Fig. 5 D) , suggests that the resting intracellular glucose concentration is significantly 
Effect of HK overexpression on glucose metabolism in ARVM and NRVM
To measure how HK levels affect glucose metabolism, we overexpressed HKIYFP and HKIIYFP in NRVM and ARVM. Our Westernblot data analysis indicates that overexpression of HKI and HKII caused a twotofive fold increase in HK levels (Fig. S3) . In ARVM (Fig. 6 A) , overexpression of HKI markedly accelerated the rate of glucose utilization measured in the presence of Cyto B (Fig. 6 A, white vs. gray traces) , decreasing the halftime from 493 s (95% CI [446, 534] , n = 7) to 89 s (95% CI [75 103], n = 8; Fig. 6 B) . This result corresponds to an effect size of 404 s, 95% CI (449, 356) on the half time of glucose utilization (i.e, a 5.6fold decrease, [4.7, 6 .7]; Fig. 6 B) . With this large increase in glucose clear ance due to HKI overexpression, the difference in the halftime of the FRET ratio change associated with glu cose clearance between AVRM and NRVM decreased to 6.0fold (95% CI [4.7, 7.5]), a value comparable to other reports (Lopaschuk et al., 1991) . As a result of increased glucose utilization, the steadystate levels of intracellular glucose decreased both in the presence and absence of outside glucose (Fig. 6 F) . Thus, after overexpression of HKI the resting FRET ratio shifted from 1.32 (95% CI [1.23, 1.42]), without exogenous data with a sigmoidal curve (see Materials and methods for details). An example of sigmoidal fits obtained for AVRM and NRVM is shown in Fig. 5 C (traces labeled 1 and 2 in panels A and B, respectively).
In ARVM (n = 7), exposure to the GLUT inhibitor Cyto B dramatically decreased the rate of glucose clearance upon glucose removal (Fig. 5 A) , with the halftime increasing by +432 s (95% CI [386, 474] ) (i.e., an 8.1fold increase, 95% CI [7.1, 9.1]). This ob servation indicates that in ARVM, GLUTmediated glucose efflux, rather than glycolysis, is the dominant factor regulating glucose clearance. In contrast, addi tion of Cyto B in NRVM (n = 13) had almost no effect on the rate of glucose clearance after glucose removal (Fig. 5 B) . This result suggests that glucose meta bolism, rather than glucose efflux, dominates glucose clearance in NRVM. The striking differences in glu cose handling between AVRM and NRVM are summa rized in Fig. 5 E, revealing a 33.5fold (95% CI [28.8, 40 .2]) shorter halftime in the FRET ratio change as sociated with glucose clearance in NRVM than ARVM, which is qualitatively consistent with the reportedly fivefold higher rate of glucose consumption observed during development in neonatal ventricle (Lopaschuk et al., 1991) . the very high glucose utilization rate in NRVM. This high glycolytic rate observed in NRVM is consistent with the dramatic decrease in glucose utilization ob served in these cells when IAA is present (Fig. S5) . To confirm these hypotheses, we investigated the effect of downregulating the expression of HKI and HKII, using HKI or HKII shRNA (Fig. 6 D) . Knockdown of HKI slowed glucose utilization in NRVM (Fig. 6 D, white vs. gray traces), resulting in a significant pro longation in the halftime of the FRET ratio change associated with glucose clearance from 15 s (95% CI [13, 17] , n = 13) to 34 s (95% CI [30, 39] , n = 7), i.e., a 2.3fold decrease (95% CI [1.9, 2.8]; Fig. 6 E) . In contrast, downregulation of HKII had no effect (Fig. 6 D, gray vs. black traces) , with the halftime of the FRET ratio change associated with glucose utili zation remaining unchanged (12 s, 95% CI [11, 14] , n = 5, for HKIIKO vs. 15 s, 95% CI [13, 17] , n = 13, for WT; Fig. 6 E) .
In three out of four cases where we tested the effects of overexpression of HKII in ARVM and HKI and HKII in NRVM, we did not observe any increase in the rate of FRET ratio change associated with glucose utilization, HKI to 1.50 (95% CI [1.43, 1.58]; P = 0.0165) with over expressed HKI. In contrast, overexpression of HKII did not affect glucose utilization in ARVM (Fig. 6 A, black vs. gray traces), with the halftime of the FRET ratio change associated with glucose utilization remain ing similar to wildtype (WT) cells (465 s, 95% CI [407, 521] , n = 9; Fig. 6 B) . As a result, steadystate intracellu lar glucose levels in the presence and absence of extra cellular glucose were not affected by overexpression of HKII. In NRVM (Fig. 6 C) , however, overexpression of HKI or HKII had no significant effect on glucose utiliza tion rate (Fig. 6 C, white, gray, and black traces) , with similar halftimes of FRET ratio decline associated with glucose utilization observed for nontransfected samples (15 s, 95% CI [13, 17] , n = 13), HKI overexpression (12 s, 95% CI [10, 15] , n = 5), and HKII overexpression (17 s, 95% CI [13, 20] , n = 6; Fig. 6 E) . Similarly, the steady state FRET ratio levels in the presence and absence of extracellular glucose were not affected by overexpres sion of either HKI or HKII.
Together with RTPCR revealing a significantly higher HKI/HKII ratio in NRVM than ARVM (Fig. S4 ), these observations suggest that HKI is responsible for Figure 6 . Effects of HKI and HKII overexpression and knockdown on glucose utilization in ARVM and NRVM. (A) In ARVM, over expression of HKI dramatically increased the rate of glucose utilization (white) compared with control (gray), whereas overexpressing HKII had no significant effect (black). (B) All the individual halftimes of the FRET ratio change associated with glucose utilization obtained for the different conditions in ARVM are represented in the dot plot. The bar plot indicates a fivefold decrease (effect size) in the halftime when HKI is overexpressed, while the values are similar to control for HKII overexpression. The error bars represents the 95% CIs of the effect size. (C) In NRVM, however, overexpression of HKI or HKII did not significantly change the halftime of the FRET ratio change associated with glucose utilization (gray, white, and black traces). (D) However, downregulation of HKI (white), but not HKII (black), dramatically slowed the halftime in NRVM, which suggests that glucose phosphorylation is performed primarily by HKI and not HKII. Downregulation of HKI and HKII using lentivirus shRNA were assessed by Western blotting and compared with WT and nontargeting shRNA (scrshRNA) preparations. (E) The dot plot shows that in NRVM, the halftime of FRET ratio change as sociated with glucose utilization is only affected (2.3fold increase, effect size in bar plot) when HKI is knocked down, but not by HKII knockdown (KO), or HKI and HKII overexpression (OE). Pvalues reported were calculated using bootstrap resampling (see Materials and methods for details).
less glycolytically active than NRVM, which is consistent with the observation that mitochondriabound HKs are associated with a higher glucose phosphorylation rate. Furthermore, overexpression of HKI but not HKII in creased the glycolytic rate in ARVM, whereas overexpres sion of HKI or HKII had little effect in NRVMs, suggesting that the activity of endogenous HKs in NRVM is near maximal. Conversely, downregulating HKI, but not HKII, significantly reduced the glycolytic rate in NRVMs. From these data, we deduce that in AVRM (1) endogenous HKI activity is quite low, (2) little HKII is bound to mitochon dria, and (3) exogenous HKII is predominantly directed to the cytosol, where it regulates glycogen synthesis and other anabolic pathways, but does not efficiently substi tute for endogenous HKI to feed glycolysis. Because over expression of HKII has no effect on the slow phase of glucose utilization when efflux is blocked in AVRM, as op posed to what was previously shown in CHO cells (John et al., 2011) , we surmise that the activity of the endo g enous HKII to synthesize glycogen must be near maxi mal. This is again consistent with our RTPCR data. In contrast, in NRVM, the basal rate of glucose phosphory lation was very high and overexpression of HKI or HKII had no effect on the rate of glucose phosphorylation. These results indicate that the level of endogenous HKs is sufficient to stimulate glucose metabolism maximally. The observation that the inhibitor IAA caused a dra matic decrease in glucose utilization in NRVM is consis tent with this hypothesis (Fig. S5) .
Unfortunately, direct quantitative comparison of the rate of glucose clearance by metabolism between ARVM and NRVM was not possible, as extrapolating the half time in FRET ratio directly to glucose consumption rate is complicated by many factors, including differences in the surfacetovolume ratio between NRVM and AVRM, the fact that NRVM were spontaneously beating and ac tively dividing whereas ARVM were quiescent, and the nonlinear relationship between FRET ratio and intracel lular glucose concentration. For these reasons, we were not able to calibrate the halftime of the decrease in FRET ratio associated with glucose clearance directly into rates of glucose utilization in micromoles per second. How ever, qualitatively, the substantially shorter halftime of the FRET ratio change associated with glucose clearance via metabolism in NRVM than in ARVM is qualitatively consistent with the previously reported greater rate of glycolysis in the NRVM (Lopaschuk et al., 1991) .
Translocation of HKs in NRVM is regulated by IAA, but not Akt
Previous findings have established G6P as an impor tant mediator promoting HKII dissociation from mito chondria to cytosol (White and Wilson, 1990; Aleshin et al., 1998; Sebastian et al., 1999) . In CHO cells over expressing HKII, but not HKI, we found that glucose removal was associated with a delay in the subsequent despite a twotofivefold increase in protein (Fig. S3) . These data together with our imaging data of HKI YFP and HKIIYFP clearly demonstrate that our trans fection of HK is highly efficient, and thus the lack of effect of exogenous HK on the rate of metabolism cannot be attributed to a lack of HK expression. Even though we were not able to get enough material to quantify the exogenous and endogenous protein lev els in ARVM, our imaging data obtained with HKIYFP and HKIIYFP clearly demonstrate that our infection protocol with the adenovirus is highly efficient. Thus, it is unlikely that the lack of effect of HKI and HKII on the rate of glucose metabolism in AVRM reflects a lack of exogenous enzyme expression.
Finally, our quantitation of HK protein levels shows that knockdown of HKI and HKII in NRVM was effi cient (Fig. 6 D) . Thus, again in this case the lack of ef fect of HKII knockdown on glucose utilization cannot be attributed to a poor depletion of endogenous HKII.
D I S C U S S I O N
In this study, we used optical methods to track in real time the subcellular distributions of HKI and HKII in normal neonatal and adult cardiac cells, which were directly correlated with glycolytic activity under varying experimental conditions. Of the four mammalian HKs, HKI and HKII are the major cardiac isoforms, with HKII levels higher in ARVM, whereas HKI is higher in NVRM (Postic et al., 1994; Smeele et al., 2011) . The RT PCR data reported here (Fig. S4 ) are in agreement with these observations. Consistent with previous biochemi cal analyses in heart tissue (Russell et al., 1992) , we show that HKI and HKII have different intracellular distri butions, and directly document, for the first time, the functional consequences on regulation of glucose meta bolism (catabolism vs. anabolism) in ARVM and NRVM. Given the known protective effects of HK binding to mi tochondria against cell death and ischemia/reperfu sion injury (Robey and Hay, 2005; Pastorino and Hoek, 2008; Smeele et al., 2011; Wu et al., 2011) , it is interest ing to speculate that the differential distribution of HKI and HKII may potentially contribute to the reduced sus ceptibility of neonatal heart to ischemiareperfusion in jury, compared with adult heart (Riva and Hearse, 1993; Ostadal et al., 1999) .
In cardiac myocytes, glycolytic activity correlates with the levels of HKI and HKII Our RTPCR data (Fig. S4 ) fit with earlier results indi cating that ARVM express high levels of HKII, whereas NRVM predominantly express HKI (Postic et al., 1994) . Although mRNA expression levels do not always cor relate with functional protein levels, our functional data using the FRET probe FLIPGlu600 µM (Fehr et al., 2003; John et al., 2008 John et al., , 2011 indicate that ARVM are that Akt signaling enhances the binding of HKII to mi tochondria (Miyamoto et al., 2008 ). Thus, a high level of basal Akt activity in NRVM might also explain the lack of response to glucose removal. However, this pos sibility is unlikely because preincubation with Akt in hibitor IV in NRVM failed to restore HKII dissociation from mitochondria in response to glucose removal. This result suggests that, in NRVM, Akt is not a primary regu lator of HKII binding to mitochondria, but rather a modulator of its sensitivity to G6P.
In summary, our findings indicate that HKI and HKII exhibit similar properties in normal native cardiac tissue as in tumor cell lines, despite pathophysiological alterations that may be present in the latter. HKII, the predominant isoform in ARVM, dynamically distributes between the mi tochondria and cytoplasm in a G6P-dependent manner. In contrast, HKI, the predominant isoform in NRVM re mains bound to mitochondria. In ARVM, overexpression of HKI, but not HKII, increased glycolytic activity, whereas in NRVM, knockdown of HKI, but not HKII, decreased glycolytic activity. These results suggest that differing inter action of HKI and HKII with mitochondria plays a key role in defining the different metabolic profiles of ARVM and NRVM, accounting for the markedly increased glycolytic activity of NRVM. In future studies, it will be interesting to explore how these HK isoform-related effects on glucose metabolism and interactions with mitochondria may be related to the increased resistance of NRVM to ischemia reperfusion injury. Our results may also raise caution in extrapolating findings in NRVM to the adult heart when studying conditions such as hypertrophy and heart failure in which metabolic factors have important influences. rate of glucose phosphorylation (when Cyto B was present to block glucose efflux; John et al., 2011) . Based on our prior detailed analysis in CHO cells (John et al., 2011) , we attribute this delay to the activation of glycogenolysis when glucose was removed, which elevated G6P levels to both inhibit HKII and promote its dissociation from mitochondria. This interpretation was supported by our findings that IAA, which elevates G6P by inhibiting gly colysis distally (Fig. S2) , caused HKII to dissociate from mitochondria in intact CHO cells with glucose present, and that exogenous G6P accelerated dissociation of HKs from mitochondria in permeabilized CHO cells (John et al., 2011) .
In the present study, we have tested the effect of glu cose removal and IAA on the intracellular distribution of HKI and HKII in both AVRM and NRVM. Consistent with our findings in CHO cells, either removal of glucose or addition of IAA in the presence of glucose displaced HKII from mitochondria in AVRM, while having no ef fect on HKI. In NRVM, however, removal of glucose did not cause HKII to dissociate from mitochondria, al though IAA in the presence of glucose did. This observa tion may be explained assuming that either less glycogen is synthesized in NRVM, because most HK is bound to mitochondria, or that glycogen degradation into G6P is a slow process in these cells. In either case, removal of glucose does not appear to raise G6P levels sufficiently to induce HKII dissociation from mitochondria. IAA, how ever, permits glucose phosphorylation but blocks glyco l ysis downstream, leading to G6P accumulation (Fig. S2) , which causes HKII to dissociate from mitochondria.
It was recently suggested that G6Pinduced HKII translocation from ARVM mitochondria outer mem brane required an acidic pH i (<7.0; Pasdois et al., 2012) . This possibility warranted further investigation, as it was also recently found that removal of extracellular glucose may cause a decrease in intracellular pH from 7.4 to 7.0 in live Neuro2A cells (Tantama et al., 2011) . To investigate whether a change in intracellular pH is necessary to facilitate G6P-induced HKII transloca tion, we measured intracellular pH with the BCECF probe after removal of glucose or addition of IAA in CHO cells and NRVM (Fig. S6) . In both cell types re moval of glucose had little effect of intracellular pH, and if anything there was a slight alkalinization, due perhaps to decreased lactate production. In the case of IAA, we observed a small (<0.05 U) but transient acidi fication (Fig. S6) . Based on these results, we conclude that in our case the elevation of G6P caused by IAA or glucose removal (Fig. S2) evokes HKII dissociation independently of intracellular acidification.
We also previously found that expression of constitu tively active Akt in CHO cells strengthened the interac tion of HKII with mitochondria so that glucose removal no longer induced its translocation to the cytosol (John et al., 2011) , which is consistent with studies showing
